AlzChem Group AG
FSX:ACT.DE
55.2 (EUR) • At close November 7, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) EUR.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 540.649 | 542.223 | 422.293 | 379.257 | 376.072 | 375.217 | 353.92 | 327.185 | 329.212 | 298.358 | 301.763 | 287.384 | 0 | 0 | 0 | 0 |
Cost of Revenue
| 404.102 | 259.499 | 153.955 | 128.676 | 138.793 | 143.048 | 129.944 | 241.403 | 144.304 | 127.598 | 133.034 | 127.811 | 0 | 0 | 0 | 0 |
Gross Profit
| 136.547 | 282.724 | 268.338 | 250.581 | 237.279 | 232.169 | 223.976 | 85.782 | 184.908 | 170.76 | 168.729 | 159.573 | 0 | 0 | 0 | 0 |
Gross Profit Ratio
| 0.253 | 0.521 | 0.635 | 0.661 | 0.631 | 0.619 | 0.633 | 0.262 | 0.562 | 0.572 | 0.559 | 0.555 | 0 | 0 | 0 | 0 |
Reseach & Development Expenses
| 11.413 | 10.788 | 9.688 | 9.363 | 9.31 | 8.678 | 9.015 | 8.658 | 8.601 | 7.986 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 12.731 | 11.354 | 11.169 | 17.084 | 17.731 | 17.791 | 18.93 | 40.384 | -1.013 | 96.514 | 92.081 | 86.415 | 0 | 0 | 0 | 0 |
Selling & Marketing Expenses
| 21.048 | 28.269 | 18.027 | 14.887 | 16.383 | 19.554 | 16.497 | 0.997 | 1.044 | 1.033 | 0.93 | 0.921 | 0 | 0 | 0 | 0 |
SG&A
| 58.993 | 39.623 | 29.196 | 31.971 | 34.114 | 37.345 | 35.427 | 41.381 | 0.031 | 97.547 | 93.011 | 87.336 | 0 | 0 | 0 | 0 |
Other Expenses
| -13.899 | 212.534 | 201.6 | 186.095 | 172.911 | 155.063 | 154.715 | 0.028 | 0.031 | 0.01 | 0.004 | 0.004 | 0.005 | 0.013 | 0.005 | 0.005 |
Operating Expenses
| 84.305 | 252.157 | 230.796 | 218.066 | 207.025 | 192.408 | 190.142 | 0.028 | 0.031 | 0.01 | 0.004 | 0.004 | 0.005 | 0.013 | 0.005 | 0.005 |
Operating Income
| 52.242 | 39.086 | 38.215 | 31.008 | 30.85 | 34.446 | 32.152 | -0.028 | -0.031 | -0.01 | -0.004 | -0.004 | -0.005 | -0.013 | -0.005 | -0.005 |
Operating Income Ratio
| 0.097 | 0.072 | 0.09 | 0.082 | 0.082 | 0.092 | 0.091 | -0 | -0 | -0 | -0 | -0 | 0 | 0 | 0 | 0 |
Total Other Income Expenses Net
| -4.053 | 2.196 | -1.703 | -3.81 | -5.358 | -2.527 | -2.816 | -0 | 0 | 0 | 0 | 0 | 0 | 0.002 | 0 | 0 |
Income Before Tax
| 48.189 | 41.282 | 36.512 | 27.198 | 25.492 | 31.919 | 29.336 | -0.029 | -0.031 | -0.01 | -0.004 | -0.004 | -0.005 | -0.011 | -0.005 | -0.005 |
Income Before Tax Ratio
| 0.089 | 0.076 | 0.086 | 0.072 | 0.068 | 0.085 | 0.083 | -0 | -0 | -0 | -0 | -0 | 0 | 0 | 0 | 0 |
Income Tax Expense
| 13.397 | 11.059 | 8.748 | 7.333 | 7.345 | 9.136 | 8.764 | 0 | 0 | -0.002 | -0 | -0 | -0 | -0.002 | -0 | -0 |
Net Income
| 34.621 | 30.052 | 27.593 | 19.694 | 17.976 | 22.644 | 20.393 | -0.029 | -0.031 | -0.008 | -0.004 | -0.004 | -0.005 | -0.011 | -0.005 | -0.005 |
Net Income Ratio
| 0.064 | 0.055 | 0.065 | 0.052 | 0.048 | 0.06 | 0.058 | -0 | -0 | -0 | -0 | -0 | 0 | 0 | 0 | 0 |
EPS
| 3.4 | 2.97 | 2.72 | 1.94 | 1.77 | 2.23 | 2 | -0.003 | -0.14 | -0.036 | -0.02 | -0.017 | -0.021 | -0.049 | -0.024 | -0.022 |
EPS Diluted
| 3.4 | 2.97 | 2.72 | 1.94 | 1.77 | 2.23 | 2 | -0.003 | -0.14 | -0.036 | -0.02 | -0.017 | -0.021 | -0.049 | -0.024 | -0.022 |
EBITDA
| 78.142 | 64.629 | 62.689 | 54.105 | 50.342 | 55.576 | 46.179 | -0.028 | -0.031 | -0.01 | -0.004 | -0.004 | -0.005 | -0.013 | -0.005 | -0.005 |
EBITDA Ratio
| 0.145 | 0.119 | 0.148 | 0.143 | 0.134 | 0.148 | 0.13 | -0 | -0 | -0 | -0 | -0 | 0 | 0 | 0 | 0 |